Association of gender, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis

Journal of the American Academy of Dermatology

Volumn 69, Issue 4, 2013, Pages 650-651

  Wu, Jashin J ^a   Poon, Kwun Yee T ^b  

^a LOS ANGELES MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB;

CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; LETTER; PRIORITY JOURNAL; PSORIASIS; SEX DIFFERENCE;

EID: 84884292963     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.04.035     Document Type: Article

References (3)

1. J. Channual, J.J. Wu, and F.J. Dann Effects of TNF-alpha blockade on metabolic syndrome in psoriasis: lessons learned from rheumatoid arthritis and psoriatic arthritis Dermatol Ther 22 2009 61 73
2. D.H. Solomon, E. Massarotti, R. Garg, J. Liu, C. Canning, and S. Schneeweiss Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis JAMA 305 2011 2525 2531
3. J.J. Wu, K.T. Poon, J.C. Channual, and A.Y. Shen Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis Arch Dermatol 148 2012 1244 1250